MarketPulse — Real-Time Financial News & Market Analysis

Gafrik Research initiates BUY coverage on GEVORKYAN with 12.34 EUR price target, implying 26% upside. Strong H1 2025 results with 8.7% revenue growth and 17.2% EBITDA expansion.

Falcon Oil & Gas to delist from AIM following merger completion with Tamboran Resources. Shareholders vote March 11, with delisting effective mid-March 2026.

Investors shift from mega-cap tech to value stocks in Q1 2026, favoring defensive consumer staples like Walmart amid AI spending concerns and valuation reassessment.

Schall Law Firm sues Ardent Health for securities fraud, alleging material misrepresentations about accounts receivable practices and insurance coverage between July 2024 and November 2025.

Vallourec and Baker Hughes partner to develop underground hydrogen storage technology, combining storage and compression systems for green hydrogen infrastructure across industrial applications.

Rivian's stock rallies below $20 ahead of its mass-market R2 SUV launch in Q2 2026, targeting $45,000 starting price and 62,000-67,000 deliveries.

Global cash logistics market expected to double to $69.9B by 2035, driven by persistent currency demand in developing economies and growing outsourced cash management services.

Ardent Health faces securities class action for allegedly inflating receivables through misleading accounting practices. Class period runs July 2024 through November 2025.

Amazon stock down 14% YTD amid $200B AI spending plans, but AWS shows strength with 24% revenue growth and $244B contract backlog, signaling long-term positioning.

Schall Law Firm files class action against Charming Medical over SEC trading suspension, alleging securities fraud from coordinated social media promotion scheme driving suspicious stock spike.

Investors increasingly turn to defensive ETF strategies like Treasury and bond funds to protect portfolios amid market volatility concerns after years of significant S&P 500 gains.

KDDI faces securities investigation over delayed earnings disclosure and potential misleading business information. Stock fell 11.4% as Rosen Law Firm explores class action litigation for shareholders.

Rosen Law Firm sues Inovio Pharmaceuticals for allegedly making false statements about manufacturing capabilities and regulatory timelines, causing investor losses through inflated stock prices.

Endeavor Group Holdings faces securities lawsuit over alleged false merger disclosures regarding share valuation, executive pay, and conflicts of interest. Lead plaintiff deadline: March 18, 2026.

BellRing Brands faces securities lawsuit alleging it misrepresented sales growth, attributing gains to inventory buildup rather than organic demand. Lead plaintiff deadline: March 23, 2026.

Bloom Energy stock surges on AI data center demand with $20B backlog. Company reached profitability and partnered with Brookfield and Oracle, but trades at elevated 100x P/E ratio.

Kyndryl investors face April 13 deadline to become lead plaintiff in securities class action over financial reporting failures and misstatements.

Coca-Cola appoints new CEO and Chief Digital Officer to drive modernization and growth, leveraging strong brand, diverse portfolio, and consistent dividend history.

Constellation Energy fell 32% amid rate cap concerns, but benefits from strong tech demand and long-term power contracts that provide revenue visibility and growth potential.

Securities lawsuit against uniQure alleges misleading FDA disclosure statements about gene therapy candidate AMT-130. Stock fell 49% after November FDA feedback; investors must file claims by April 13, 2026.